Cargando…
RNAi Therapeutics in Autoimmune Disease
Since the discovery of RNA interference (RNAi), excitement has grown over its potential therapeutic uses. Targeting RNAi pathways provides a powerful tool to change biological processes post-transcriptionally in various health conditions such as cancer or autoimmune diseases. Optimum design of shRNA...
Autores principales: | Pauley, Kaleb M., Cha, Seunghee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816694/ https://www.ncbi.nlm.nih.gov/pubmed/24276020 http://dx.doi.org/10.3390/ph6030287 |
Ejemplares similares
-
Presence of Porphyromonas gingivalis in gingival squamous cell carcinoma
por: Katz, Joseph, et al.
Publicado: (2011) -
RNAi Therapeutic Platforms for Lung Diseases
por: Fujita, Yu, et al.
Publicado: (2013) -
Autoantibodies against Muscarinic Type 3 Receptor in Sjögren's Syndrome Inhibit Aquaporin 5 Trafficking
por: Lee, Byung Ha, et al.
Publicado: (2013) -
Formation of GW/P bodies as marker for microRNA-mediated regulation of innate immune signaling in THP-1 cells
por: Pauley, Kaleb M., et al.
Publicado: (2009) -
A status report on RNAi therapeutics
por: Vaishnaw, Akshay K, et al.
Publicado: (2010)